搜索临床试验以:瑞替加滨 900 毫克/天
总计7848个结果
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales Servier尚未招聘具有 IDH1 突变、未经治疗或之前接受过 1 种全身治疗方案治疗的局部晚期或转移性传统软骨肉瘤
-
University of Patras完全的
-
Ferozsons Laboratories Ltd.未知
-
University of MichiganNational Institute on Aging (NIA)完全的
-
Chinese PLA General HospitalTianjin TongRenTang Group Co., Ltd.未知
-
Bayer完全的
-
Cardiff UniversityCancer Research UK未知
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; Qilu Hospital of Shandong University; First Hospital of China Medical University 和其他合作者招聘中
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.邀请报名
-
Dong-A ST Co., Ltd.尚未招聘
-
Norwegian University of Science and TechnologySt. Olavs Hospital完全的
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; Talkspace主动,不招人
-
Chong Kun Dang PharmaceuticalCholine Alfoscerate Re-evaluation Consortium (57 pharmaceutical companies)尚未招聘
-
Sir Mortimer B. Davis - Jewish General HospitalCancer Research Network终止
-
MacroGenics终止反洗钱美国, 英国, 德国, 以色列, 西班牙, 法国, 意大利, 荷兰
-
Sunnybrook Health Sciences CentreUnity Health Toronto完全的
-
Otsuka Beijing Research InstituteZhejiang Otsuka Pharmaceutical Co., Ltd.完全的
-
Kaiser PermanenteCity of Hope National Medical Center撤销
-
Bayer招聘中
-
National Cancer Institute (NCI)主动,不招人难治性淋巴瘤 | 难治性恶性实体瘤 | 复发性尤文肉瘤 | 复发性淋巴瘤 | 复发性恶性实体瘤 | 难治性尤文肉瘤 | 复发性肺泡横纹肌肉瘤 | 难治性肺泡横纹肌肉瘤美国, 加拿大
-
Northwestern UniversityNational Cancer Institute (NCI); Bayer完全的
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre Laboratories主动,不招人
-
Leap Therapeutics, Inc.BeiGene主动,不招人
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan完全的